Contract facts
FederalNo full NAICS 325411 intel page yet. Browse NAICS intelligence
4558649412!LEVOFLOXACIN SOLUTION FOR INJ., 750MG/30 is a federal award for Dla Troop Support held by Akorn, Inc. Estimated value $166K ($166K obligated). Current period of performance ends Oct 5, 2022. Place of performance: LAKE FOREST IL.
4558649412!LEVOFLOXACIN SOLUTION FOR INJ., 750MG/30
Recompete timing
PublicCurrent PoP ended Oct 5, 2022 (1416 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract SPE2D322F579D?
SPE2D322F579D (4558649412!levofloxacin solution for INJ. 750mg) is a Dla Troop Support award with a potential value of $166K, currently held by Akorn, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded SPE2D322F579D?
Dla Troop Support awarded SPE2D322F579D to Akorn, Inc (potential $166K).
Who is the incumbent on SPE2D322F579D?
Akorn, Inc is the incumbent. The current period of performance ends Oct 5, 2022.
When does Akorn, Inc’s SPE2D322F579D come up for recompete?
SCOUT tracks a period-of-performance end of Oct 5, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.